Table 2.
Correlations of c-Met, LMP-1, and Ets-1 Expressions with Lymph Node Metastasis in Nasopharyngeal Carcinoma
| Total | c-Met | LMP-1 | Ets-1 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Negative (<10%) | Positive (≧10%) | P value | Negative (<10%) | Positive (≧10%) | P value | Negative (<10%) | Positive (≧10%) | P value | ||
| Lymph Node Metastasis | ||||||||||
| Negative | 8 | 5 | 3 | 0.0156 | 6 | 2 | 0.0172 | 6 | 2 | 0.0284 |
| (12.8%) | (7.7%) | (15.4%) | (5.1%) | (15.4%) | (5.1%) | |||||
| Positive | 31 | 6 | 25 | 9 | 22 | 10 | 21 | |||
| (15.4%) | (64.1%) | (23.1%) | (56.4%) | (25.6%) | (53.8%) | |||||
LMP-1: latent membrane protein-1. The results for c-Met, LMP-1, and Ets-1 were classified into negative and positive categories depending on the percentage of immunoreactive tumor cells: negative, <10% immunoreactive cells; positive, ≧10% immunoreactive cells.